| GTO ID | GTC0964 |
| Trial ID | ChiCTR2200055490 |
| Disease | Solid Tumor |
| Altered gene | MESO |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | GC503 |
| Phase | Early_Phase1 |
| Recruitment status | Recruiting |
| Title | An early exploratory clinical study of targeting mesothelin chimeric antigen receptor T cells (GC503) in the treatment of mesothelin-positive advanced solid tumors |
| Year | 2022 |
| Country | China |
| Company sponsor | The First Affiliated Hospital of Zhengzhou University |
| Cohort 1 | |||||||||
|
|||||||||